Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include disposable blood perfusion devices, disposable plasma bilirubin adsorbers, DNA immunoadsorption column and blood purification equipment. The company offers products for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders. Jafron Biomedica was founded on December 19, 1989 and is headquartered in Zhuhai, China.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

ExThera Medical, based in Martinez, Calif., is targeting the clinical treatment of blood-borne diseases including viremia and bacteremia, as well as the removal of harmful substances present in banked human blood. For example, the treatment of bacteremia, caused by S. aureus or MRSA (Methicillin-Resistant S. aureus) usually relies heavily on antibiotics. ExThera Medical’s Seraph® device uses the affinity of bacteria to immobilized heparin within the device, to bind the pathogen and lower its concentration in the bloodstream. Naturally-occurring heparin is a well-known anticoagulant that has many other useful biological properties making Seraph® a ‘biomimetic therapeutic device’. It can be an adjunct to anti-infective drugs by reducing the load and duration of infection, potentially preventing complications and the systemic inflammatory response that leads to organ failure. When no effective drugs are available Seraph may help patients recover by supplementing their own immune systems.

CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.

Jiangsu Charui Biotechnology Co., Ltd., established on 2020-06-16, Business scope includes licensed projects:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based material polymerization technology;Research and development of bio-based materials technology;Biomass Energy Technology Services;Biochemical product technology research and development;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Experimental analysis instrument sales;Instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Changguo Biomedical Technology Hebei Co., Ltd., established on 2019-11-26, Business scope includes bioengineering,Technology research and development of medical devices,Technology Promotion;functional polymer material,Medical polymer materials and products,blood purification device,Hemoperfusion device production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xierkang (希尔康血液) is a Chinese high-tech enterprise engaged in the research and development, production, and clinical research of blood purification equipment. The company has committed itself to the research and production of blood hemoperfusion apparatus. Its product portfolio includes six domains of resin adsorption column, resin carbon adsorption column, bilirubin adsorption column, low density cholesterol protein adsorption column, endotoxin adsorption column, and specific adsorption column. Xierkang is focused on the development of hemoditoxifier, and owns the proprietary intellectual property rights for its raw material synthesis, specialized equipment production, and tank body design.

Langfang Aier Medical Technology Co., Ltd., established on 1993-10-11, Business scope includesIIIkind10-04Research and design of blood purification and peritoneal dialysis equipment,manufacture,Sales,After-sales service,technical consulting,Technical Services;Class I,Class II,Wholesale of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Foshan Boxin Biotechnology Co., Ltd., established on 2009-11-25, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Changzhou Huaye Minimal Invasive Medical Devices Co. Ltd. manufactures cardiopulmonary bypass and blood processing equipments. The company is headquartered in China.

Kangyuan Medical Technology (Dalian) Co., Ltd., established on 2016-11-18, Business scope includes licensed projects:Production of Class III Medical Devices,Class III medical device business,Production of Class II Medical Devices,pharmaceutical production,pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Sales of Class II Medical Devices,Production of Class I Medical Devices,Sales of Class I Medical Devices,Pharmaceutical commissioned production,Manufacturing of medical packaging materials,Engineering and Technology Research and Experimental Development,Medical Research and Experimental Development,Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology),R&D and application of cell technology,Research and development of bio-based materials technology,Research and development of bio-based material polymerization technology,Manufacturing of bio-based materials,Sales of bio-based materials,Biochemical product technology research and development,Fermentation process optimization technology research and development,New material technology research and development,Domestic trade agent,Technology Import and Export,Import and export,Import and export agency(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Beijing Zhongke Shengkang Technology Co., Ltd., established on 2008-12-24, The business scope includes the sale of third-class medical devices;technology development,technical consulting,Technical Services,technology transfer;product design;sell cosmetics,Chemical Products(Free of Hazardous Chemicals),Toy,Office Supplies,crafts(Does not contain cultural relics),furniture,knitted goods,electronic product,Equipment,computer,Software and Auxiliary Equipment,daily necessities,Clothing and shoes,plastic products,Class I medical device,Class II medical device;Import and export;Technology Import and Export;Agent import and export;Medical equipment and equipment manufacturing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Zibo Kangbei Medical Equipment Co., Ltd., established on 2001-06-19, Business scope includes licensed projects:Production of Class III Medical Devices;Production of Class II Medical Devices;Class III medical device business;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);New material technology research and development;Import and export;Technology Import and Export;Glassware Sales;Instrument sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chongqing Guanxin Precision Mould Co., Ltd., established on 2012-09-06, Business scope includes general items:Mold processing,manufacture;Sales:Mold accessories,Machinery Parts,D;manufacture,Sales:plastic product.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Tianjin Younas Biotechnology Co., Ltd., established on 2013-01-31, Business scope includes medical devices,Medical Consumables,Biological and medical reagents,Research and development of biological and medical materials,Technical Consulting and Technical Services;Class III:6845-4Production of blood purification equipment and blood purification appliances,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu OCI Medical Devices Co., Ltd. is a private company headquartered in Chengdu, China, that manufactures and wholesales dialysis testing & blood purification equipment.